PPT-Hemophilia March 11, 2016
Author : trish-goza | Published Date : 2018-03-07
By NamY7 Hemophilia was first recognized by the Jews but not officially named even in the ancient times In the 2 nd century AD the Talmud a Jewish collection of
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Hemophilia March 11, 2016" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Hemophilia March 11, 2016: Transcript
By NamY7 Hemophilia was first recognized by the Jews but not officially named even in the ancient times In the 2 nd century AD the Talmud a Jewish collection of Rabbinical writings said that the boys did not have to be circumcised if two brothers died of the disease In 1800s it became known as the Royal Disease because many people of royal families died or got the disease Queen Victoria got Hemophilia but she survived Alexei the heir apparent to the Russian royal family suffered from Hemophilia In 1950s the first treatment to hemophilia appeared It was in a type called fresh frozen plasma Nowadays we are marching towards a cure but there are two treatments One is called gene therapy and the other is called Recombinant therapy A treatment for hemophilia is replacing old blood clots with new ones. Nairobi, Kenya. June 24, 2013. Jim Munn, R.N., M.S.. Program Nurse Coordinator. University of Michigan HTC. Ann Arbor, MI, USA. Chair – WFH Nursing . Committee. Acknowledgement. : . Slides 20,21, 23-28 . (. H. aemophilia). By: Morgan Dirienzo. The Royal Disease. Alternate Names and Symptoms. Some alternate names for Hemophilia would be Haemorrhaphilia, or Von Willebrand disease. . The Symptoms for Hemophilia are…. Introduction/Overview. Introduction/Overview (cont). Importance of Prophylaxis, and Limitations on Its Application, in Hemophilia B. Key Unmet Need in Hemophilia B:. Reducing Patient Burden of Disease. Implementing . the Participant Individual Record Layout (PIRL). A Quality . Model for Student Success. 1. Series Webinar 5. Carrie Tupa. Texas Workforce Commission. March 24, 2016. Defining Student Success in . Implementing . the Participant Individual Record Layout (PIRL). A Quality . Model for Student Success. 1. Series Webinar 5. Carrie Tupa. Texas Workforce Commission. March 24, 2016. Defining Student Success in . June. , . 2013. Roger L. Lundblad, Ph.D.. Consultant in Biotechnology. Chapel Hill, North Carolina. http://www.lundbladbiotech.com. And Adjunct Professor, Department of Pathology,. University of North Carolina, Chapel Hill, North Carolina. Sex-linked inheritance; almost all patients male. Female carriers may have mild symptoms. Most bleeding into joints, muscles; mucosal and CNS bleeding uncommon. Severity inversely proportional to factor level. . Peterson, Owen Comer, Quaevon Anderson, and Grace Hodges. Basic Information . Grace. . Hemophilia A. Classic hemophilia. Factor VIII deficiency. Hemophilia B. Christmas disease. Factor IX deficiency. A new ambition of the World Federation of Hemophilia. WFH Guidelines for the Management of Hemophilia. All recommendations are consensus based.. Srivastava A et al. Haemophilia. 2020;26(Suppl 6):1–158. . WVNHF. Amber Tichnell, Executive Director. Hemophilia and other bleeding disorders. The human body is made up of several clotting factors – Factors 1 through 13 plus Von . Willebrand. Factor. A person can have deficiencies in any of these factors. Hemophilia A. Also known as Factor VIII Deficiency is the most common type of hemophilia. It is a disorder of your blood-clotting system. Clotting is the process which your blood changes from a liquid to a solid state. Andrew J. . Costandi. , MD, MMM . Children’s Hospital Los Angeles. USC Keck School of Medicine. Faculty Disclosures. None. Learning Objectives. Upon completion of this activity, participants will be able to:. Dr. S. Parthasarathy . MD., DA., DNB, MD (. Acu. ), . Dip. Diab.DCA, Dip. Software statistics . PhD (. physio. ). . Mahatma . gandhi. medical college and research institute, . puducherry. , India. Alfonso Iorio, MD PhD. McMaster University, Canada. Alfonso Iorio. MD, PhD, FRCPC. Professor of Medicine. McMaster University. Disclosures. McMaster University has received research, consultancy and educational funding for Population PK projects from Bayer, .
Download Document
Here is the link to download the presentation.
"Hemophilia March 11, 2016"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents